Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
REVENUE:        
Product revenue, net $ 17,234 $ 3,290 $ 37,656 $ 7,717
COSTS AND EXPENSES:        
Cost of sales 1,252 1,367 3,533 5,582
Research and development 25,824 9,289 63,454 27,545
Selling, general and administrative 45,590 25,701 110,173 52,007
 Total operating expenses 72,666 36,357 177,160 85,134
Operating loss (55,432) (33,067) (139,504) (77,417)
Contract income 666 982 1,266 2,941
Loss on extinguishment of debt (2,092)
Interest income, net 1,362 1,231 4,140 2,713
Other income (expense), net 75 (1,156) 23 (3,256)
Net loss available to common stockholders $ (53,329) $ (32,010) $ (134,075) $ (77,111)
Net loss per common share, basic $ (2.89) $ (3.59) $ (8.24) $ (10.42)
Net loss per common share, diluted $ (2.89) $ (3.59) $ (8.24) $ (10.42)
Weighted average common shares outstanding, basic 18,440,773 8,922,792 16,278,383 7,403,400
Weighted average common shares outstanding, diluted 18,440,773 8,922,792 16,278,383 7,403,400